While most methods for predicting cancer T cell epitopes evolve around MHC binding prediction, which is a necessary step for an epitope to be recognized by T cells, other factors, such as the abundance of the epitope (or its precursors) in the tumor and the availability of a TCR repertoire capable of recognizing the epitope, influence T cell recognition. Here, HLA-C is linked to cancer.